Mel Gibson claims Covid drug paralyzed him and killed his friend in shocking admission to Joe Rogan

Mel Gibson claims that he was left paralyzed for three months after taking a popular Covid drug used to treat Donald Trump. 

The 69-year-old actor opened up on Joe Rogan‘s podcast about his harrowing experience with remdesivir in 2020.

He revealed that he got Covid soon after his gardener contracted the virus, and they both went to the same hospital and were given the antiviral medication.

Manufactured by California-based Gilead Sciences Inc, the medication was the first one approved for emergency use in the US to treat severely ill Covid patients. 

But Gibson suggests the drug, which is administered via an IV infusion, ‘killed’ his gardener and friend of 20 years, while he was left with severe side effects. 

He revealed on Rogan’s show: [My gardener and I] both went to the same hospital and he died and I didn’t. I think we both got remdesivir which is not good. 

‘I couldn’t walk for three months after I had that stuff… because it kills you. I found that afterwards, it kills you.’

According to the Cleveland Clinic, remdesivir has a number of side effects including allergic reactions, breathing problems, diarrhea and nausea – but not paralysis or muscle weakness. 

Remdesivir can cause confusion and faintness which could make walking difficult. 

By contrast, Covid itself is known to impact the nervous system in rare cases and cause movement issues.

Scientists from the NIH explain on the government agency’s website that after an initial infection, people who have had Covid may develop a variety of inflammatory syndromes affecting the brain, spinal cord, or nerves. 

If the inflammation affects an area of the brain responsible for movement and sensory information, it could lead to paralysis. 

They say the type of paralysis Covid could trigger would typically start in the lower limbs and spread to the upper limbs. 

Several large studies looking at remdesiver and Covid found the drug was linked to an up to a 62 percent lower risk of death in hospital, including one by the NIH.

One study, funded by Gilead, showed patients who received remdesivir within 10 days of symptom onset had improved outcomes compared with those treated after more than 10 days of symptoms. 

Gibson first went public with his Covid diagnosis in July 2020.

His representative at the time revealed that he spent a week in a Los Angeles hospital in April after testing positive for the virus. 

But following treatment, he tested negative and was able to return home.  

Sold under the brand name Veklury, remdesivir was developed by Gilead Sciences to treat Ebola, the deadly hemorrhagic fever that emerged in West Africa in 2014.

It works by blocking an enzyme that helps the coronavirus make copies of itself and, in turn, spread throughout the body.

The antiviral – given to patients intravenously as part of a five-day – was used to treat President Trump and former White House doctor Anthony Fauci said the US should share it with the world during the early days of the Covid.

The federal government quickly went about amassing a stockpile of the drug.

While several studies supported remdesivir’s benefits, one by the World Health Organization (WHO) later claimed it did not improve Covid survival odds. 

In a study commissioned by the organization, remdesivir was given to 2,750 out of over 11,000 patients between March and early October 2020. 

The $2,340 treatment course did little to improve survival odds or to shorten recovery for people with Covid.

Now back in good health, Gibson says he is working on living a longer, healthier life, with one of his techniques being the 30:30:30 diet.

The method – touted by biohacker Gary Brecka – involves eating 30 grams of protein within 30 minutes of waking up followed by 30 minutes of steady-state cardiovascular exercise such as walking. 

Regular saunas and stem cell therapies, are other health habits favored by Gibson.